A developmental alternative splicing switch, involving exon 16 of protein 4.1 pre-mRNA, occurs during mammalian erythropoiesis. By controlling expression of a 21 -amino acid peptide required for high-affinity interaction of protein 4.1 with spectrin and actin, this switch helps to regulate erythrocyte membrane mechanical stability. Here we show that key aspects of protein 4.1 structure and function are conserved in nucleated erythroid cells of the amphibian Xenopus laevis. Analysis of protein 4.1 cDNA sequences cloned from Xenopus erythrocytes and oocytes showed that tissue-specific alternative splicing of exon 16 also occurs in frogs. Importantly, functional studies with recombinant Xenopus erythroid 4.1 demonstrated specific binding to and mechanical stabilization of 4.1-deficient human erythrocyte membranes. P ROTEIN 4.1 is a structural component of the erythroid membrane skeleton, which contributes to the mechanical integrity and deformability of the red blood cell via its interactions with other skeletal elements. It facilitates spectrin cross-linking of short actin filaments and thus stabilizes the hexagonal protein network underlying the lipid bilayer. Genetic disruption of the ternary complex between spectrin, actin, and protein 4.1 results in red blood cells with fragile membranes and abnormal elliptical morphology. Protein 4.1 has also been shown to bind integral membrane proteins, including glycophorins',' and band 3,3 suggesting a role in anchoring the skeleton to the bilayer; however, the physiologic significance of such interactions is still uncertain. Further associations between 4. l and myosin, tubulin, p55, and calmodulin have also been Molecular cloning experiments have demonstrated that 4.1 gene expression is a highly regulated process involving complex alternative splicing of pre-mRNA transcribed from a single large 4.1 gene, predicting the existence of an extensive family of closely related 4.1 polypeptides."" Indeed, a multiplicity of 4.1 proteins has been detected by immunoblotting extracts of mammalian'* and tissues, raising many interesting questions about the structure-function relationships among the various isoforms. Do all of the above binding functions reside in a single polypeptide chain, or do specific structural isoforms interact with subsets of the other skeletal elements? Similarly, do various isoforms exhibit different affinities for these skeletal ligands? How is expression of this diversity regulated?
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Recent studies of the 10-kD spectrin-actin binding domain of protein 4.1 afford answers to some of these questions. Alternative splicing of three distinct small exons, encoding peptides of 19, 14, and 21 amino acids, can generate eight structurally variant domains with potentially different functional characteristics. Biochemical and biophysical assays performed with recombinant 4.1 peptide isoforms have conclusively shown that protein 4.1 isoforms require the 21 -amino acid sequence encoded by exon 16 for high-affinity spectrin Moreover, upon incorporation into protein 4.1 -deficient red blood cells, isoforms containing Phylogenetic sequence comparison showed two evolutionarily conserved peptides that represent candidate spectrinactin binding sites. Finally, in situ hybridization of early embryos showed high expression of 4.1 mRNA in ventral blood islands and in developing brain structures. These results demonstrate that regulated expression of structurally and functionally distinct protein 4.1 isoforms, mediated by tissue-specific alternative splicing, has been highly evolutionarily conserved. Moreover, both nucleated amphibian erythrocytes and their enucleated mammalian counterparts express 4.1 isoforms functionally competent for spectrinactin binding. This is a US government work. There are no restrictions on its use.
this peptide can increase membrane strength to normal levels,Is whereas 4.1 isoforms lacking the 21 amino acids are inactive at comparable concentrations. These results demonstrate a clear functional difference among alternative protein 4.1 i~oforms.'~.'' Protein 4.1 isoform expression is regulated at the level of pre-mRNA splicing, in tissue-and differentiation-specific fashion. In early erythroid precursors, including human proerythroblasts and mouse erythroleukemia cells, the splicing machinery skips exon 16 of 4.1 pre-mRNA?,l','x The resulting spliced mRNA encodes a truncated 10-kD domain with much lower affinity for ~pectrin-actin.",'~.'~ Subsequently, in more differentiated erythroblasts, an alternative splicing switch leads to incorporation of exon 16 and synthesis of an intact spectrin-actin binding domain. This switch appears roughly correlated with assembly of a mechanically stable erythroid membrane.*'
In mammalian systems, then, differentiation-specific regulated switches in pre-mRNA splicing patterns generate 4.1 isoforms exhibiting different functional interactions with other skeletal elements. Although cDNAs for protein 4 Expression of recombinant 4.1 peptides. For in vitro expression, pBS-ATG plasmids containing human or frog cDNA inserts were transcribed and translated in cell-free wheat germ extracts (Promega) in the presence of ("S)-methionine as previously described." The human "l0Kz1" peptide consisted of 87 amino acids extending from G l~~-> G l y~~~ "; the frog "XIOKZ1" peptide spanned the corresponding residues of the frog 4.1 sequence. "10K" refers to the chymotryptically defined region responsible for spectrin-actin binding, and "21" denotes inclusion of the 21-amino acid cassette critical for function (Fig 2) . Bacterial expression of recombinant 10K peptides was performed" using the pGEX-KG vector to yield 10K2' or X1OKz' peptides fused with the GST moiety to facilitate purification by glutathione-agarose affinity chromatography.26
MATERIALS AND METHODS

Reagents
Incorporation of recombinant 4.1 peptides into normal red blood cell membranes. "S-labeled peptides synthesized in vitro were incorporated into membranes as described p r e v i o u~l y .~~.~~ Briefly, normal red blood cells were hypotonically lysed on ice with 10 mom sodium phosphate, incubated with labeled peptides at approximately IO-' mol/L, and resealed by addition of KCVMgCI, and incubation at 37°C for 20 minutes. Membrane ghosts were then hypotonically lysed again and washed thoroughly with lysis buffer before counting the specifically bound peptide. The reconstitution proced~re".~' with human and frog GST-1OK fusion proteins used membranes completely deficient in protein 4.1 and peptide concentrations of approximately l mg/mL. Lysis and resealing were performed as above, except that resealing time was extended to 60 minutes. Protein 4.1 -deficient red blood cellszx were obtained through Dr Gil Tchernia (HBpital BicStre, Kremlin-Bicetre, France).
Red blood cell membrane fragmentation assay.
Resealed red blood cell membranes were suspended in 35% dextradphosphatebuffered saline and subjected to a high-shear laminar flow as previously described.*' Briefly, the large deformations, quantified by forward light-scattering in the ektacytometer, led to a progressive fragmentation of intact membranes into smaller, less deformable vesicles manifested as a decline in the deformation index with time.
Embryos and embryonic explants. Xenopus laevis embryos were obtained using standard procedures and staged according to the method of Nieuwkoop and Faber.'' Female frogs were induced to lay eggs by gonadotropin injection. Eggs were fertilized in vitro using macerated testes. Embryos were dejellied in 0.3% cysteine hydrochloride and 0.1 X MMR, pH 7.6, and cultured in 0.1 X MMR ( I X MMR = 100 mmol/L NaCI, 2 mmol/L KCI, 1 mmoVL MgSO,, 2 mmol/L CaCL, 5 mmol/L HEPES, pH 7.6, and 0. I mmol/L EDTA).
Whole-embryo in situ hybridization, immunohistochemistry, and histology. Whole-embryo in situ hybridization was performed using albino embryos as previously described.30,3i The antisense RNA probe was a 425-nt transcript from the PCR product generated with oligos 3 and 4; the transcript was labeled by incorporation of digoxigenin-coupled undine triphosphate (Boehringer, Mannheim, Germany). Sense riboprobes were used to confirm specificity. The hybridization signal was detected by incubation with alkaline phosphatase coupled to antidigoxigenin Fab fragments (Boehringer), followed by the chromogenic reaction with nitro blue tetrazolium (NBT) and 5-bromo-1 -chloro-3-indolyl phosphate (BCIP) (Promega). To view internal staining, some embryos were cleared in 2: 1 benzyl benzoate:benzoic acid and viewed by Nomarski optics using a Nikon Microphot-FXA (Melville, NY). a similar RTPCR strategy, except that a new pair of oligonucleotide primers specific for the Xenopus 4.1 cDNA sequence were used. In oocytes (lane 8) or 64-cell embryos (not shown), two PCR products were produced, indicating that amphibian 4.1 pre-mRNA is also alternatively spliced in the region around exon 16. To define precisely the structure of these products, each was subcloned and subjected to DNA sequence analysis. The lower band was essentially identical to the published Xenopus oocyte 4. I cDNA in this region," ie, containing sequences with weak homology to the mammalian exon 14 but no sequences similar to exons 15 or 16. In contrast, the upper band contained an additional insert of 63 nt with high homology to the mammalian exon 16. Xenopus nucleated red blood cells expressed predominantly the larger form containing exon 16 (lane 7). These experiments demonstrate that expression of multiple structural isoforms of protein 4.1, regulated by alternative pre-mRNA splicing, has been phylogenetically conserved through evolution from amphibians to mammals.
RESULTS
Alternative splicing
Phylogenetic consenjotion of 4. I prirnnn structure. As a first step toward exploring phylogenetic conservation of protein 4.1 structure and function in the spectrin-actin binding domain, amino acid sequences of mammalian, amphibian, and avian 4.1 species were compared. Figure 2A shows the spectrin-actin binding domain sequences encoded by alternative exon 16 and constitutive exon 17; residues that differ from the human sequence are shaded. All three mammalian 4.1 proteins (human, mouse, and dog) were identical in this region, except for a substitution of Ile'" + Leu in the dog (which lies distal to the minimal spectrin-actin binding domain"."). Chicken and frog 4.1 exhibit strong overall sequence identity (-80%) to mammalian 4.1 in this region. Within the 21 -amino acid alternative peptide required for functional binding to spectrin, absolute conservation of Gly4'J-GI~J'7 is observed, including the potential regulatory phosphorylation site at Tyr4IX.j3 Equally conserved is a second region of IS amino acids in the downstream constitutive sequence ( P r~~~~-P r o '~' ) :
again, this peptide contains a potential regulatory phosphorylation site at Ser""." The high evolutionary conservation of these two amino acid stretches identifies them as candidate binding sites for the interaction of protein 4. I with spectrin and/or actin.
To determine whether phylogenetic sequence conservation might identify other functionally important domains of 4. I , comparisons of known human"'.zs.'h and frog" sequences were extended to include the full coding region. Figure 2B shows these results. Surprisingly, several areas with less well-defined functions were conserved equally to the spectrin-actin binding domain. The entire 30K putative membrane-associated domain and a portion of the adjacent 16K domain, spanning approximately 440 amino acids, were about 80% identical between frog and human 4.1 Near the C-terminal end of 30K are several conserved sequences of 15 to 25 amino acids that are identical in human, mouse, 
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>SO% identity <SO% identity and frog, and are candidates for mediating interaction between 4.1 and glycophorin C or band 3. Likewise, the Cterminal 22K to 24K domains of these two proteins were approximately 80% identical, suggesting that this region may have important (as yet uncharacterized) functions in erythroid or nonerythroid cells. In contrast, two regions of 4.1 were less evolutionarily conserved. A span of approximately 65 amino acids immediately preceding the spectrin-actin binding domains was variable even among mammalian species. This short region was only 60% to 70% identical in painvise comparisons, and in fact exhibited small deletiodinsertions that were not observed elsewhere. The frog 4.1 sequence exhibited substantially less homology to the mammalian species; in fact, heterogeneity was observed even among multiple frog 4.1 cDNAs amplified from a single source, probably due to the tetraploid nature of the frog genome. The second region of reduced homology was in the extended amino-terminus expressed only in high-molecular-weight 4.1 via the alternatively spliced upstream AUG. Here, two short regions of nearly identical sequence (97% to 100%) are interspersed among much longer regions of lower identity (-35%). This pattern suggests, first, that sufficient time has elapsed for sequence divergence of functionally unimportant residues between frog and human 4.1, and, second, that the short conserved peptides likely play an important role in 4.1 function.
Functional interaction between frog 4.1 and mammalian spectrin-actin. To determine whether the observed phylogenetic sequence conservation was accompanied by conserved function, we tested the ability of a recombinant frog 4.1 peptide to function in a heterologous system with mammalian membrane skeletal proteins. Previous studies have demonstrated that recombinant peptides of human 4. I, containing the alternative 21 amino acids, are functional in biochemical and biophysical assays involving interactions with human erythroid spectrin and rabbit muscle actin.Is.I6 Radiolabeled peptide X1OK2', encompassing the putative spectrinactin binding domain of frog 4.1 including the 21 amino acids encoded by exon 16, was synthesized via in vitro transcription and translation. This peptide is analogous to the human 10K2' peptide described earlier,I5 which retained full spectrin binding activity. Specific association of both frog and human peptides with human red blood cell membranes was measured using a hypotonic lysis/resealing pr0cedure.2~ Figure 3 shows that the human 10K2' peptide binds strongly to membranes (Kapp -IO'/moVL, calculated as in Discher et all7), whereas a "nonerythroid" 10K peptide isoform lacking the 21 amino acids (designated IOK") fails to bind under these conditions. Heterologous binding of X10K2' to human membranes was approximately 10-fold above the nonerythroid lOK" background, albeit with reduced apparent affinity as compared with the human peptide (-40%).
We also performed a more stringent test of XlOK*' peptide function by assaying whether it could incorporate into and thereby mechanically strengthen protein 4.1 -deficient red blood cell membranes. The deformability index declines as a function of time as the membranes fragment in response to the applied shear field (Fig 4) . Red blood cells with 100% deficiency of protein 4.1 begin to fragment quickly when subjected to shear stress (lower curve, 4.1( -)). Incorporation of recombinant fusion protein GST-10K" into red blood cell membranes by exchange hemolysis resulted in restoration of membrane stability to approximately 86% of normal in this experiment (indicated by the increased lag time before decline of the deformability index in comparison to the lag time for red blood cells with normal 4.1 content, not shown). GST-10K2' encompasses the spectrin-actin binding site of human 4.1 and serves as a positive control; it has been shown previously to be as equally effective on a molar basis as intact protein 4.1 in restoring membrane ~tabi1ity.I~ Membranes incorporating the frog 4.1 fusion protein GST-XlOK" restored membrane stability to approximately 67% of normal, ie, slightly less efficiently than the homologous human peptide. In control experiment^,'^ we have determined that the stabilization effect is specific, since fusion proteins lacking the 21 amino acids do not restore membrane stability at the same mass concentration.
One additional functional test of GST-XlOK" showed that it was capable of interacting in vitro with human spectrin and rabbit muscle actin, in a falling-ball viscometry assay, to form a viscous gel (data not shown). Although not as effective as human GST-10K2' at the same apparent concentration,I5 this result again indicates that frog 4.1 can form a ternary complex with heterologous spectrin and actin.
Expression of protein 4.1 mRNA in developing emblyos. To determine the temporal and spatial patterns of protein 4.1 expression during early embryogenesis of the frog, we performed in situ hybridization of antisense digoxigeninlabeled 4.1 RNA probes on whole-frog embryos staged from gastrulation until blood island formation. A high level of 4.1 expression was observed at stage 17 in the developing central nervous system (data not shown), well before formation of erythroid elements in the ventral blood islands. Brain staining remained intense throughout development, at least to stage 37 (Fig SA to D) . Examination of stage 35 embryos showed high-level staining in ventral blood islands (Fig SA, arrows) and in erythroid cells within the heart (Fig 5B, arrows) in a pattern similar to that observed earlier for erythroid globin (Fig SE) and transcription factor GATA-1 probe^.^' As a control, sense-strand probes gave no signal (data not shown). Interestingly, the punctate ventral staining was lost in an anterior to posterior direction at stage 37, during a time when the entire blood island enters the circulation (Fig SC, arrow) . This temporal correlation between the known stage of blood island disappearance and the observed loss of ventral staining further supports the identity of these structures as bona fide blood islands rather than another ventral structure. The central nervous system continues to express high levels of 4.1 mRNA at this time, including the forebrain, midbrain, hindbrain (arrows), and the eye.
DISCUSSION
The results presented here demonstrate considerable evolutionary conservation in the expression and function of protein 4.1 in both mammals and amphibians. First, we clearly show that frog erythrocytes express an isoform of protein 4.1 that is structurally and functionally homologous to mammalian erythroid 4.1 in the 10-kD region responsible for high-affinity binding to spectrin and actin. Amino acid sequence comparison showed approximately 80% identity in primary sequence between frog and human 4.1 in this domain, including identical peptides of 14 amino acids (in alternative exon 16) and 15 amino acids (in constitutive exon 17). Secondary structure predictions for human and frog 10-kD peptides were similar. The phylogenetic homology implied functional conservation; indeed, by several biochemical and biophysical criteria, the frog 10K peptide did interact effectively with mammalian skeletal proteins. The identical conserved peptides, which are also identical in chicken 4.1 ,38 are prime candidates for protein interaction sites. However, the inability of the frog 10K peptide to substitute fully for the corresponding human peptide indicates that other residues are also likely to affect the affinity of protein 4.1 interactions with other skeletal proteins.
A second evolutionarily conserved feature of the protein 4.1 gene is alternative pre-mRNA splicing: both frogs and mammals use tissue-specific regulation of exon 16 alternative splicing. Thus, although nonerythroid cells of both species recognize this exon poorly, erythroid cells incorporate exon 16 efficiently into mRNA. Such splicing patterns predict tissue-specific functional differences in protein 4.1 isoforms; erythroid 4.1 bears a complete spectrin-actin binding domain including the essential 21 amino acids encoded by exon 16, whereas much nonerythroid 4.1 lacks this peptide and therefore the binding function.
These findings also have important implications in terms of conservation of alternative splicing mechanism(s), both with respect to the nuclear machinery that regulates 4.1 premRNA splicing and presumably also with respect to the cis-acting regulatory sequences within the pre-mRNA itself. Indeed, we have recently confirmed that frog oocyte nuclei have the capacity to perform accurate alternative splicing of a microinjected synthetic mouse 4.1 pre-~nRNA.~~ By comparison of conserved nucleotide sequences within and surrounding a given alternative exon, it may be possible to discern residues required for function in much the same way we have identified candidate functional amino acid residues in the structural protein.
Outside the 10-kD domain, considerable homology is also observed between frog and human 4 . 1 : ' In fact, 80% sequence identity was observed over the entire N-terminal30-kD domain, with some stretches of even greater conservation. This observation implies strong functional conservation in this domain as well, possibly related to the putative membrane associations commonly ascribed to this region. Moreover, an equally high conservation is found between the carboxy-terminal domains, implying the existence of as yet undocumented functions residing in this domain. The significance of these homologies is underscored by the fact that two regions of the protein (the 16-kD domain and the Nterminal extension) are not well conserved, demonstrating that sufficient evolutionary time has elapsed to allow sequence divergence in less critical domains. With respect to alternative splicing previously characterized in these domains, little is known about the functional consequences for ance of embryonic globins, and therefore appears to be a marker of terminal differentiation of the erythroid compartment. Its expression was also high in particular regions of the developing central nervous system, implying a specialized function. This latter observation is consistent with earlier findings that expression of antisense 4.1 mRNA had adverse effects on retina development.21 Moreover, the requirement for 4.1 in brain suggests that complete knockout of the 4.1 gene may be lethal, and may in part explain the curious pattern of genetic mutations of 4.1 in patients with hereditary elliptocytosis and complete deficiency of 4.1 in red blood cells. Phenotypically, affected individuals in two unrelated families exhibited mechanically fragile red blood cells with hemolytic anemia but no obvious neurologic defect. Genetically, the sparing effect of the mutations on brain may be explained by the isoform-specific nature of the gene defects. In both cases, mutations selectively blocked expression of approximately 80-kD isoforms of erythroid 4.1 while permitting continued expression (from a different translation initiation site) of high-molecular-weight isoforms in nonerythroid tissues. @ '-41 Erythroid differentiation in mammals is accompanied by dramatic changes in form and function as cells enucleate and a stable membrane skeletal network of proteins is established. Membranes of mature red blood cells appear more deformable and more mechanically stable than those of their reticulocyte precursors.*' Underlying these observed alterations in membrane material properties are regulated changes in gene expression involving both transcriptional activation of erythroid-specific genes and switches in pre-mRNA splicing. An example of the latter is the switch in the 4.1 alternative splicing pattern that occurs within the 10-kD coding sequences mentioned earlier. Alternative splicing has also been described as a mechanism responsible for generating tissue-specific differences in the C-terminal structure of mammalian P-spectrin in red blood cells versus m~s c l e .~* .~~ Thus far, relatively little is known about expression of membrane skeletal proteins in nucleated red blood cells. It will be interesting to determine to what extent they resemble mammalian red blood cell gene regulation, ie, whether they express erythroid versus nonerythroid spectrins (fodrins), whether erythroid-specific alternative splicing events in pspectrin or other genes occur, and whether genes transcribed in both erythroid versus nonerythroid cells use separate promoter elements. The present study demonstrates that at least one key feature of skeletal protein expression in erythroid cells-selective expression of protein 4.1 isoforms capable of forming a ternary complex with spectrin and actin-is conserved between nucleated amphibian and enucleated mammalian red blood cells.
